99% of the U.S. population lives within listening range of at least one public media station.

And everyone can listen to NPR podcasts free of charge.

That means you get completely unpaywalled access to stories, prize-winning reporting,

and shows that represent the voices in every corner of the country.

Hear the bigger picture every day on NPR.

You're listening to Shortwave.

From NPR.

Hey, shortwavers.

Chances are you've heard about psychedelics, once or twice.

And Shortwave producer Rachel Carlson has been diving into the science behind them.

She's joining me this week to talk all about them. Hey, Rachel. Hey, Gina. So psychedelics are

being studied to treat lots of different kinds of conditions. Chronic Lyme disease, Alzheimer's disease,

anorexia nervosa, chronic back pain, obsessive compulsive disorder, post-traumatic stress disorder.

That's Albert Garcia-Rameo. He's a psychologist and psychopharmacologist at Johns Hopkins University.

Albert ran a study using a psychedelic called psilocybin. It's the active ingredient in magic mushrooms.

And he wanted to see if it could help people who'd previously had Lyme disease.

Oh.

Because you may not realize it, but Lyme disease often comes with lots of psychological symptoms

in addition to all the physical ones.

Lori Unruh Snyder is one of Albert's patients in that study.

She's an agriculture professor.

She got a tick bite.

...